The European Commission has approved a tablet version of the already approved drug Evrysdi from Swiss company Roche.
发布者：BY CHRISTOPHER DUE KARLSSON，转转请注明出处：https://robotalks.cn/roches-neuromuscular-disease-tablet-receives-eu-approval/
Roche’s neuromuscular disease tablet receives EU approval
赞 (0)
关于作者
Toyota, Daimler Finalize Plan to Merge Truck Units in 2026
上一篇
10 6 月, 2025 1:17 下午
Novo Nordisk refutes link between Wegovy and eye disease
下一篇
10 6 月, 2025 1:18 下午
相关推荐
-
Circus SE plant Übernahme des AI-Agent Unternehmens FullyAI für revolutionäre Interaktion zwischen Mensch und KI
HAMBURG, Deutschland–( ORGANIZATION CABLE)– Circus SE (XETRA: CA1), ein weltweit führendes Unternehmen für Physical AI-Anwendungen, plant pass away Übernahme von FullyA…
-
Can AI truly replicate the screams of a man on fire? Video game performers want their work protected
For hours, movement seize sensors tacked onto Noshir Dalal’s physique tracked his actions as he unleashed aerial strikes, overhead blows and single-handed assaults that will …
-
AI bots easily bypass some social media safeguards, study reveals
While expert system (AI) robots can offer a genuine objective on social networks– such as advertising or client service– some are made to adjust public conversation, pr…
-
Exotic Key West Paradise With Its Own Thatched Tiki Hut Hits the Market for $3.3 Million
Absolutely nothing claims holiday residential or commercial property fairly like a home with its extremely own thatched Tiki hut. Whether you are seeking a financial investment res…
-
Aphea.Bio Submits US EPA Approval for first biofungicides VALORIA™ and VIRTUOSA™
Aphea.Bio, a number one supplier of microbial options for agriculture, publicizes the submission of purposes for VALORIA and VIRTUOSA, its first biofungicides, to acquire federal a…
